Market intelligence, corporate strategy and investment insights
Founded by pharmaceutical industry experts, PHARMAnetwork is an independent publishing company focused on the analysis of contract pharmaceutical and biopharmaceutical markets for industry decision-makers.
PHARMAnetwork magazine offers authoritative insight on global CDMO and contract manufacturing markets, covering market intelligence, corporate strategy, investments and Capex, finance and M&A, regulatory affairs, and legal compliance.
Issue No. 68 - April 2026
Discover our latest edition featuring strategic CDMO insights, investment perspectives and industry analysis.
CDMO strategy
The model based on producing at the lowest cost, optimized to the extreme, has revealed its vulnerability in the face of health, geopolitical, and climate crises. Now, the priority is to produce closer to home, more safely, and more sustainably, making resilience a strategic issue for competitiveness and sovereignty.
FINANCE & M&A
The CDMO sector is no longer simply a hierarchy of margins or multiples. It is now organized around distinct industrial trajectories, where the ability to invest, integrate, and scale up becomes as crucial as immediate profitability.
FINANCE & M&A
A cross-analysis of three key indicators—labor productivity (EBIT per employee), profitability (EBITDA margin), and valuation (EV/EBITDA)—enriched by a fourth, often underestimated dimension, the level of investment (Capex), allows for a more in-depth understanding. It reveals not only a sectoral hierarchy, but above all, profoundly different business models
LEGAL & COMPLIANCE
The current geopolitical situation, particularly the closure of strategic shipping routes, raises questions about the resulting supply tensions and their impact on the relationships between subcontractors and prime contractors. This article aims to provide an overview of the main legal aspects and issues arising from this exceptional situation, which has significant repercussions for subcontractors and prime contractors alike
Discover PHARMAnetwork magazine at leading industry events in Europe and the US
in print or digital.
Independent media dedicated to bio / pharmaceutical outsourcing
All content is developed within a rigorous editorial framework, ensuring objectivity and long-term perspective.
Analysis of CDMO operations, investments, regulatory frameworks and industrial transformations.
Analysis of CDMO market dynamics across Europe, the United States and key Asian manufacturing hubs.
Content designed for decision-makers across pharmaceutical companies, biotechs and CDMOs.